Insider Trading Summary for Valeant Pharmaceuticals International, Inc. (BHC): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
19-May-23 4:19 PM View:	19-May-23 Grant 0	Power Robert N Director		Valeant Pharmaceuticals International, Inc. - BHC	22% 135.81K to 165.02K	0	0	--	--	Show Txns Hide Txns

19-May-23 4:24 PM View:	19-May-23 Grant 0	Ross Thomas W. Sr. Director		Valeant Pharmaceuticals International, Inc. - BHC	22% 132.31K to 161.52K	0	0	--	--	Show Txns Hide Txns

01-Apr-24 4:29 PM View:	29-Mar-24 Grant $6.86K	Wechsler Amy B Director		Valeant Pharmaceuticals International, Inc. - BHC	24% 137.5K to 169.91K	0	0	--	--	Show Txns Hide Txns

01-Apr-24 4:30 PM View:	29-Mar-24 Grant $31.25K	Robertson Russel C Director		Valeant Pharmaceuticals International, Inc. - BHC	24% 181.53K to 225.28K	0	0	--	--	Show Txns Hide Txns

19-May-23 4:13 PM View:	19-May-23 Grant 0	Kavanagh Sarah B Director		Valeant Pharmaceuticals International, Inc. - BHC	25% 117.45K to 146.65K	0	0	--	--	Show Txns Hide Txns

01-Apr-24 4:33 PM View:	29-Mar-24 Grant $62.49K	Paulson John Director		Valeant Pharmaceuticals International, Inc. - BHC	39% 150.01K to 208.31K	0	0	--	--	Show Txns Hide Txns

01-Apr-24 4:31 PM View:	29-Mar-24 Grant $33.12K	Icahn Brett Director		Valeant Pharmaceuticals International, Inc. - BHC	70% 63.87K to 108.5K	0	0	--	--	Show Txns Hide Txns

19-May-23 4:14 PM View:	19-May-23 Grant 0	Miller Steven D Director		Valeant Pharmaceuticals International, Inc. - BHC	24% 120.31K to 149.52K	0	0	--	--	Show Txns Hide Txns

04-Mar-24 4:19 PM View:	01-Mar-24 Payment of Exercise ($1.16M)	Appio Thomas Chief Executive Officer Director		Valeant Pharmaceuticals International, Inc. - BHC	40% 981.12K to 1.37M	0	0	--	--	Show Txns Hide Txns

04-Mar-24 4:16 PM View:	04-Mar-24 Sale (Planned) ($61.87K)	Carson Seana EVP, General Counsel		Valeant Pharmaceuticals International, Inc. - BHC	13% 443.24K to 499.9K	0	0	--	--	Show Txns Hide Txns

19-May-23 4:16 PM View:	19-May-23 Grant 0	Mulligan Richard Director		Valeant Pharmaceuticals International, Inc. - BHC	80% 36.7K to 65.91K	0	0	--	--	Show Txns Hide Txns

04-Mar-24 4:24 PM View:	01-Mar-24 Payment of Exercise ($31.53K)	Barresi John S SVP, Controller & CAO		Valeant Pharmaceuticals International, Inc. - BHC	39% 77.04K to 107.06K	0	0	--	--	Show Txns Hide Txns

06-Sep-23 4:29 PM View:	05-Sep-23 Payment of Exercise ($366.97K)	Vadaketh Tom George EVP, Chief Financial Officer		Valeant Pharmaceuticals International, Inc. - BHC	(7%) 608.88K to 564.93K	0	0	--	--	Show Txns Hide Txns

Valeant Pharmaceuticals International, Inc. (BHC)

Last Year

30-Apr-23 -- 29-Apr-24

Company Sentiment

Drug Delivery

Drugs

Two Year Chart

30-Apr-22 -- 29-Apr-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	0	--